A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone
Arthritis & Rheumatism,  Clinical Article

Kremer JM et al. – In patients with active rheumatoid arthritis (RA) in whom the response to methotrexate (MTX) has been inadequate, the addition of tofacitinib at a dosage >3 mg twice daily showed sustained efficacy and a manageable safety profile over 24 weeks.

Methods
  • In this 24–week, double–blind, phase IIb study, patients with active RA (n = 507) were randomized to receive placebo or tofacitinib (20 mg/day, 1 mg twice daily, 3 mg twice daily, 5 mg twice daily, 10 mg twice daily, or 15 mg twice daily).
  • All patients continued to receive a stable dosage of MTX.
  • The primary end point was the American College of Rheumatology 20% improvement criteria (ACR20) response rate at week 12.

Results
  • At week 12, ACR20 response rates for patients receiving all tofacitinib dosages ≥3 mg twice daily (52.9% for 3 mg twice daily, 50.7% for 5 mg twice daily, 58.1% for 10 mg twice daily, 56.0% for 15 mg twice daily, and 53.8% for 20 mg/day) were significantly (P ≤ 0.05) greater than those for placebo (33.3%).
  • Improvements were sustained at week 24 for the ACR20, ACR50, and ACR70 responses, scores for the Health Assessment Questionnaire disability index, the 3–variable Disease Activity Score in 28 joints using the C–reactive protein level (DAS28–CRP), and a 3–variable DAS28–CRP of <2.6.
  • The most common treatment–emergent adverse events occurring in >10% of patients in any tofacitinib group were diarrhea, upper respiratory tract infection, and headache; 21 patients (4.1%) experienced serious adverse events.
  • Sporadic increases in transaminase levels, increases in cholesterol and serum creatinine levels, and decreases in neutrophil and hemoglobin levels were observed.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Rheumatology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Rheumatology Articles

1 Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: A nationwide cohort study Annals of Rheumatic Diseases, July 14, 2014    Clinical Article

2 Is minor salivary gland biopsy more than a diagnostic tool in primary Sjogren's syndrome? Association between clinical, histopathological, and molecular features: A retrospective study Seminars in Arthritis and Rheumatism, July 1, 2014    Clinical Article

3 Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis Joint, Bone, Spine, July 3, 2014    Clinical Article

4 Methotrexate and lung disease in rheumatoid arthritis – A meta-analysis of randomized controlled trials Arthritis & Rheumatism, December 27, 2013    Evidence Based Medicine    Review Article    Clinical Article

5 Anti-TNF-{alpha} therapy in patients with refractory uveitis due to Behcet's disease: A 1-year follow-up study of 124 patients Rheumatology, July 8, 2014    Clinical Article

6 Anti-cyclic citrullinated peptide antibody as a marker of erosive arthritis in patients with systemic lupus erythematosus: A systematic review and meta-analysis Lupus, July 11, 2014    Clinical Article

7 Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women American Journal of Clinical Nutrition, July 18, 2014    Review Article

8 Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: Drug-exposure limitations of oral methotrexate at doses >=15 mg may be overcome with subcutaneous administration Annals of Rheumatic Diseases, July 10, 2014    Clinical Article

9 An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegeners) Annals of Rheumatic Diseases, July 2, 2014

10 Therapeutic benefit of balneotherapy and hydrotherapy in the management of fibromyalgia syndrome: A qualitative systematic review and meta-analysis of randomized controlled trials Arthritis Research & Therapy, July 9, 2014    Evidence Based Medicine    Review Article

11 Ultrasound-detected musculoskeletal urate crystal deposition: Which joints and what findings should be assessed for diagnosing gout? Annals of Rheumatic Diseases, July 14, 2014    Clinical Article

12 Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis Seminars in Arthritis and Rheumatism, July 8, 2014    Clinical Article

13 Diagnostic accuracies of sialography and salivary ultrasonography in Sjögren`s syndrome patients: A meta-analysis Clinical and Experimental Rheumatology Online, July 16, 2014    Clinical Article

14 Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate Clinical and Experimental Rheumatology Online, July 7, 2014    Clinical Article

15 Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs - a systematic review and network meta-analysis Full Text Health and Quality of Life Outcomes , July 22, 2014    Free full text    Evidence Based Medicine    Review Article

16 Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: A systematic review and meta-analysis Seminars in Arthritis and Rheumatism, June 27, 2014    Evidence Based Medicine    Review Article

17 Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study Rheumatology, February 11, 2014    Clinical Article

18 Joint damage progression in patients with rheumatoid arthritis in clinical remission. do biologics perform better than synthetic antirheumatic drugs? The Journal of Rheumatology, July 22, 2014    Clinical Article

19 Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: A non-inferiority randomised controlled trial Annals of Rheumatic Diseases, July 16, 2014    Clinical Article

20 Relation of temperature and humidity to the risk of recurrent gout attacks American Journal of Epidemiology, July 11, 2014    Clinical Article

Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatologymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close